Characterization and spatial distribution of infiltrating lymphocytes in medullary, and lymphocyte-predominant triple negative breast cancers

被引:0
|
作者
Alfaro, A. [1 ]
Catelain, C. [1 ]
El-Masri, H. [2 ]
Rameau, P. [1 ]
Lacroix-Triki, M. [3 ]
Scoazec, JY. [3 ]
Marty, V. [3 ]
Mosele, F. [2 ,4 ]
Pistilli, B. [2 ]
机构
[1] Gustave Roussy, UMS AMMICa, CNRS UAR 3655, INSERM US23, 114 Rue Edouard Vaillant, F-94805 Villejuif, France
[2] Gustave Roussy, Dept Med Oncol, Breast Cancer Unit U981, 114 Rue Edouard Vaillant, F-94805 Villejuif, France
[3] Gustave Roussy, Dept Pathol, 114 Rue Edouard Vaillant, F-94805 Villejuif, France
[4] Gustave Roussy, INSERM U981, Villejuif, France
关键词
DUCTAL CARCINOMA; TUMORS;
D O I
10.1038/s41523-024-00691-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Medullary carcinoma of the breast (MedBC) is a rare histological type that accounts for less than 5% of all invasive breast cancers. Here, we performed an exploratory study aimed to determine whether imaging mass cytometry (IMC) can be used to characterize the immune infiltration and the spatial distribution heterogeneity in the rare subtype of MedBC compared to atypical MedBC and TNBC-TILS+ tumors. In both MedBC and TNBC-TILs+, there was a notable enrichment of immune cells in the peripheral regions of the tumors, whereas in atypical MedBC, the immune cells exhibited a central enrichment pattern. This distribution of infiltrated cells reflects an active immune recruitment correlated to more favorable prognosis. In MedBC, spatial analysis shows that immune cells are localized at a greater distance from the tumor cells. IMC highlights the heterogeneity of immune microenvironment across three main subtypes of breast tumors and could help to define distinct immune patterns.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Spatial distribution of B cells and lymphocyte clusters as a predictor of triple-negative breast cancer outcome
    Juliana C. Wortman
    Ting-Fang He
    Shawn Solomon
    Robert Z. Zhang
    Anthony Rosario
    Roger Wang
    Travis Y. Tu
    Daniel Schmolze
    Yuan Yuan
    Susan E. Yost
    Xuefei Li
    Herbert Levine
    Gurinder Atwal
    Peter P. Lee
    Clare C. Yu
    npj Breast Cancer, 7
  • [42] Spatial distribution of B cells and lymphocyte clusters as a predictor of triple-negative breast cancer outcome
    Wortman, Juliana C.
    He, Ting-Fang
    Solomon, Shawn
    Zhang, Robert Z.
    Rosario, Anthony
    Wang, Roger
    Tu, Travis Y.
    Schmolze, Daniel
    Yuan, Yuan
    Yost, Susan E.
    Li, Xuefei
    Levine, Herbert
    Atwal, Gurinder
    Lee, Peter P.
    Yu, Clare C.
    NPJ BREAST CANCER, 2021, 7 (01)
  • [43] Prognostic impact of tumor infiltrating lymphocytes (TIL's) and stromal-infiltrating lymphocytes (SIL's) in triple negative breast cancer
    Sherwell-Cabello, S.
    Maffuz-Aziz, A.
    Bautista-Pina, V.
    Labastida-Almendaro, S.
    Camacho-Ramirez, D. A.
    Rios-Luna, N. P.
    Rodriguez-Cuevas, S.
    CANCER RESEARCH, 2016, 76
  • [44] Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers
    Loi, Sherene
    Drubay, Damien
    Adams, Sylvia
    Pruneri, Giancarlo
    Francis, Prudence A.
    Lacroix-Triki, Magali
    Joensuu, Heikki
    Dieci, Maria Vittoria
    Badve, Sunil
    Demaria, Sandra
    Gray, Robert
    Munzone, Elisabetta
    Lemonnier, Jerome
    Sotiriou, Christos
    Piccart, Martine J.
    Kellokumpu-Lehtinen, Pirkko-Liisa
    Vingiani, Andrea
    Gray, Kathryn
    Andre, Fabrice
    Denkert, Carsten
    Salgado, Roberto
    Michiels, Stefan
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07) : 559 - +
  • [45] Prognostic value of tumour infiltrating lymphocytes (TILs) in patients with early-stage triple negative breast cancers (TNBC) in the absence of chemotherapy
    Park, J. H.
    Jonas, S. F.
    Dieci, M. V.
    Bataillon, G.
    Criscitiello, C.
    Viale, G.
    Salgado, R. F.
    Lee, H. J.
    Loi, S.
    Kim, S. -B.
    Curigliano, G.
    Vincent-Salomon, A.
    Andre, F.
    Michiels, S.
    ANNALS OF ONCOLOGY, 2019, 30 : 55 - 55
  • [46] Zeb1 expression by tumor or stromal cells is associated with spatial distribution patterns of CD8+tumor-infiltrating lymphocytes: a hypothesis-generating study on 113 triple negative breast cancers
    Dhaou, Mona Ouled
    Kossai, Myriam
    Morel, Anne-Pierre
    Devouassoux-Shisheboran, Mojgan
    Puisieux, Alain
    Penault-Llorca, Frederique
    Radosevic-Robin, Nina
    AMERICAN JOURNAL OF CANCER RESEARCH, 2020, 10 (10): : 3370 - 3381
  • [47] Diffuse distribution of tumor-infiltrating lymphocytes is a marker for better prognosis and chemotherapeutic effect in triple-negative breast cancer
    Akira I. Hida
    Takahiro Watanabe
    Yasuaki Sagara
    Masahiro Kashiwaba
    Yoshiaki Sagara
    Kenjiro Aogi
    Yasuyo Ohi
    Akihide Tanimoto
    Breast Cancer Research and Treatment, 2019, 178 : 283 - 294
  • [48] Tumor-infiltrating lymphocyte transfusion in a patient with treatment refractory triple negative breast cancer
    Jacover, Arielle
    Zarbiv, Yonaton
    Haran, Tal Kiedar
    Klein, Shira
    Breuer, Shani
    Durst, Ronen
    Avni, Batia
    Grisariu, Sigal
    Stepensky, Polina
    Lotem, Michal
    Maimon, Ofra
    Yablonski-Peretz, Tamar
    CANCER REPORTS, 2023, 6 (12)
  • [49] Diffuse distribution of tumor-infiltrating lymphocytes is a marker for better prognosis and chemotherapeutic effect in triple-negative breast cancer
    Hida, Akira I.
    Watanabe, Takahiro
    Sagara, Yasuaki
    Kashiwaba, Masahiro
    Sagara, Yoshiaki
    Aogi, Kenjiro
    Ohi, Yasuyo
    Tanimoto, Akihide
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 178 (02) : 283 - 294
  • [50] Body Mass Index and Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer
    Floris, Giuseppe
    Richard, Francois
    Hamy, Anne-Sophie
    Jongen, Lynn
    Wildiers, Hans
    Ardui, Jan
    Punie, Kevin
    Smeets, Ann
    Berteloot, Patrick
    Vergote, Ignace
    De Croze, Diane
    Meseure, Didier
    Salomon, Anne
    Lae, Marick
    Reyal, Fabien
    Biganzoli, Elia
    Neven, Patrick
    Desmedt, Christine
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2021, 113 (02): : 146 - 153